Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedRecord history now includes last known status and verification notes, and lists sponsor organization Provectus Biopharmaceuticals, Inc. along with related topics like MedlinePlus Genetics.SummaryDifference0.6%

- Check12 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. This update appears to be metadata only and does not change study details.SummaryDifference0.1%

- Check19 days agoChange Detected- Removed the government funding status disclaimer that warned of possible delays and indicated where to find operating-status updates (cc.nih.gov; opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check26 days agoChange DetectedRemoved Melanoma and MedlinePlus Genetics from the related topics section, which are supplementary navigation links rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check33 days agoChange DetectedNo significant changes to core study content were detected. Any observed differences appear to be minor UI/layout adjustments.SummaryDifference0.4%

- Check47 days agoChange Detected- Removed MedlinePlus Genetics topic on Melanoma, narrowing the page's coverage of genetics topics related to melanoma.SummaryDifference0.2%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.